Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119622212 | 11962221 | 2 | F | 20151112 | 20160629 | 20160126 | 20160707 | EXP | GB-WATSON-2016-01199 | WATSON | 77.00 | YR | M | Y | 84.00000 | KG | 20160707 | CN | US | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119622212 | 11962221 | 1 | PS | Prednisolone (Watson Laboratories) | PREDNISOLONE | 1 | Oral | 100 MG, ONCE DAILY | UNKNOWN | 80354 | 100 | MG | UNK | QD | |||||
| 119622212 | 11962221 | 2 | SS | Cyclophosphamide (Unknown) | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1400 MG, ONCE DAILY | UNKNOWN | 0 | 1400 | MG | UNK | QD | |||||
| 119622212 | 11962221 | 3 | SS | INOTUZUMAB OZOGAMICIN | INOTUZUMAB OZOGAMICIN | 1 | Intravenous (not otherwise specified) | 0.016 MG, ONCE DAILY | .464 | MG | UNKNOWN | 0 | .016 | MG | QD | ||||
| 119622212 | 11962221 | 4 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 720 MG, ONCE DAILY | UNKNOWN | 0 | 720 | MG | QD | ||||||
| 119622212 | 11962221 | 5 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | 2 MG, ONCE DAILY | UNKNOWN | 0 | 2 | MG | QD | ||||||
| 119622212 | 11962221 | 6 | C | ONDANSETRON | ONDANSETRON | 1 | Oral | 8 MG, ONCE DAILY | UNKNOWN | 0 | 8 | MG | QD | ||||||
| 119622212 | 11962221 | 7 | C | CHLORPHENAMINE | CHLORPHENIRAMINE MALEATE | 1 | Intravenous (not otherwise specified) | 10 MG, STAT | UNKNOWN | 0 | 10 | MG | |||||||
| 119622212 | 11962221 | 8 | C | FILGRASTIM | FILGRASTIM | 1 | Subcutaneous | 300 MCG, ONCE DAILY | UNKNOWN | 0 | QD | ||||||||
| 119622212 | 11962221 | 9 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Oral | 10-20 MG, AS NEEDED | UNKNOWN | 0 | |||||||||
| 119622212 | 11962221 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, ONCE DAILY | UNKNOWN | 0 | 300 | MG | QD | ||||||
| 119622212 | 11962221 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG, ONCE DAILY | UNKNOWN | 0 | 40 | MG | QD | ||||||
| 119622212 | 11962221 | 12 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 50 MG, ONCE DAILY | UNKNOWN | 0 | 50 | MG | QD | ||||||
| 119622212 | 11962221 | 13 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, ONCE DAILY | UNKNOWN | 0 | 40 | MG | QD | ||||||
| 119622212 | 11962221 | 14 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 125 MCG, ONCE DAILY | UNKNOWN | 0 | QD | ||||||||
| 119622212 | 11962221 | 15 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Oral | 20 MG, ONCE DAILY | UNKNOWN | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119622212 | 11962221 | 1 | Diffuse large B-cell lymphoma |
| 119622212 | 11962221 | 2 | Diffuse large B-cell lymphoma |
| 119622212 | 11962221 | 3 | Diffuse large B-cell lymphoma |
| 119622212 | 11962221 | 4 | Diffuse large B-cell lymphoma |
| 119622212 | 11962221 | 5 | Diffuse large B-cell lymphoma |
| 119622212 | 11962221 | 6 | Prophylaxis |
| 119622212 | 11962221 | 7 | Adverse drug reaction |
| 119622212 | 11962221 | 8 | White blood cell count decreased |
| 119622212 | 11962221 | 9 | Prophylaxis of nausea and vomiting |
| 119622212 | 11962221 | 10 | Prophylaxis |
| 119622212 | 11962221 | 11 | Prophylaxis |
| 119622212 | 11962221 | 12 | Prophylaxis |
| 119622212 | 11962221 | 13 | Cardiac failure congestive |
| 119622212 | 11962221 | 14 | Atrial fibrillation |
| 119622212 | 11962221 | 15 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119622212 | 11962221 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119622212 | 11962221 | Lung infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119622212 | 11962221 | 1 | 20150815 | 0 | ||
| 119622212 | 11962221 | 2 | 20150820 | 0 | ||
| 119622212 | 11962221 | 3 | 20150821 | 20150918 | 0 | |
| 119622212 | 11962221 | 4 | 20150820 | 0 | ||
| 119622212 | 11962221 | 5 | 20150820 | 0 | ||
| 119622212 | 11962221 | 6 | 20150820 | 0 | ||
| 119622212 | 11962221 | 7 | 20150815 | 0 | ||
| 119622212 | 11962221 | 8 | 20150823 | 0 | ||
| 119622212 | 11962221 | 9 | 20150820 | 0 | ||
| 119622212 | 11962221 | 10 | 20150815 | 0 | ||
| 119622212 | 11962221 | 11 | 20150815 | 0 | ||
| 119622212 | 11962221 | 12 | 20150815 | 0 | ||
| 119622212 | 11962221 | 15 | 201107 | 0 |